Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AMGEN-INC-4847/news/FDA-Grants-Priority-Review-to-Amgen-s-Tarlatamab-Application-for-Advanced-Small-Cell-Lung-Cancer-45563652/?utm_source=whatsapp&utm_medium=social&utm_campaign=share